High morbidity and mortality in children with untreated congenital deficiency of leptin or its receptor
Authors:
Preprint
Abstract
BACKGROUND: Biallelic pathogenic mutations in LEP, LEPR and MC4R genes controlling central leptin-melanocortin signalling cause early onset severe obesity. However, the long-term clinical outcomes of leptin signalling deficiency are unknown. DESIGN AND OBJECTIVES: We carried out a retrospective cross-sectional clinical investigation of a large cohort of children with LEP, LEPR or MC4R deficiency, to evaluate the progression of the disease and its impact on morbidity and mortality. PARTICIPANTS: Severely obese children from 454 consanguineous families of Pakistani origin were screened for mutations in the three genes using Sanger and exome sequencing. We identified 132 probands and 13 affected family members with homozygous pathogenic mutations in LEP, LEPR or MC4R . MAIN OUTCOME MEASURES: Weight, height, and head circumference were measured by trained technicians using standardized protocols. WHO-anthro and anthroplus were used to assess BMI-standard deviation score. All affected individuals underwent detailed physical and clinical investigations by expert paediatric endocrinologist. Metabolic and oxidative stress biomarkers were measured in serum. RESULTS: We report a very high mortality in children with LEP (26%) and LEPR -deficiency (9%), mainly due to recurrent pulmonary and gastro-intestinal infections. In addition, 40% of LEP - or LEPR -deficient surviving children experienced life-threatening episodes of pulmonary or gastro-intestinal infections. Oxidative stress as assessed by biomarkers, was significantly higher in LEP deficiency compared to the other two mutant groups. CONCLUSIONS: Children with congenital deficiency of leptin or its receptor suffer a high mortality rate, and severe morbidity. Although effective therapies are available for both but as yet (or to-date) are not accessible in Pakistan. An appreciation of the severe impact of leptin or leptin receptor deficiency on educational attainment, morbidity and early mortality risks should spur efforts to deliver available life-saving drugs to these children as a matter of urgency.Keywords
All Related Versions
- Published version: Cell Reports Medicine, 4 (9), 101187.
This publication has 43 references indexed in Scilit:
- Homozygosity for a novel missense mutation in the leptin receptor gene (P316T) in two Egyptian cousins with severe early onset obesityMolecular Genetics and Metabolism, 2011
- CNS Leptin Action Modulates Immune Response and Survival in SepsisJournal of Neuroscience, 2010
- Functional Characterization and Structural Modeling of Obesity Associated Mutations in the Melanocortin 4 ReceptorEndocrinology, 2008
- Mutations in ligands and receptors of the leptin–melanocortin pathway that lead to obesityNature Clinical Practice Endocrinology & Metabolism, 2008
- Clinical and Molecular Genetic Spectrum of Congenital Deficiency of the Leptin ReceptorNew England Journal of Medicine, 2007
- Biomarkers and potential mechanisms of obesity-induced oxidant stress in humansInternational Journal of Obesity, 2005
- Human Gene Mutation Database (HGMD®): 2003 updateHuman Mutation, 2003
- A novel nonsense mutation in the melanocortin-4 receptor associated with obesity in a Spanish populationInternational Journal of Obesity, 2003
- Mutations in the human melanocortin-4 receptor gene associated with severe familial obesity disrupts receptor function through multiple molecular mechanismsHuman Molecular Genetics, 2003
- Role of leptin in the neuroendocrine response to fastingNature, 1996